0001683168-21-004020.txt : 20210831
0001683168-21-004020.hdr.sgml : 20210831
20210831182503
ACCESSION NUMBER: 0001683168-21-004020
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210810
FILED AS OF DATE: 20210831
DATE AS OF CHANGE: 20210831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waggoner Kenneth L.
CENTRAL INDEX KEY: 0001464611
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40699
FILM NUMBER: 211228161
MAIL ADDRESS:
STREET 1: 8105 IRVINE CENTER DR. #820
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER NAME:
FORMER CONFORMED NAME: Waggoner Kenneth
DATE OF NAME CHANGE: 20090520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc.
CENTRAL INDEX KEY: 0001157075
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621772151
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
BUSINESS PHONE: (917) 595.2850
MAIL ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
FORMER COMPANY:
FORMER CONFORMED NAME: NUVILEX, INC.
DATE OF NAME CHANGE: 20090324
FORMER COMPANY:
FORMER CONFORMED NAME: EFOODSAFETY COM INC
DATE OF NAME CHANGE: 20010808
3
1
ownership.xml
X0206
3
2021-08-10
0
0001157075
PharmaCyte Biotech, Inc.
PMCB
0001464611
Waggoner Kenneth L.
23046 AVENIDA DE LA CARLOTA
SUITE 600
LAGUNA HILLS
CA
92653
1
1
0
0
Chairman, CEO, Pres and GC
Common Stock
20600
D
Stock Option (right to buy)
156.00
2017-03-09
2022-03-09
Common Stock
3000
D
Stock Option (right to buy)
83.70
2018-01-01
2023-01-01
Common Stock
3000
D
Stock Option (right to buy)
74.25
2019-03-20
2024-03-20
Common Stock
3000
D
Stock Option (right to buy)
61.20
2020-01-02
2025-01-01
Common Stock
3000
D
Stock Option (right to buy)
10.05
2021-01-01
2025-12-31
Common Stock
3000
D
The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021 (the "Reverse Split").
The exercise price has been adjusted to reflect the Reverse Split.
The option vested in twelve equal monthly installments beginning on January 1, 2021.
/s/ Kenneth L. Waggoner
2021-08-31